Verifying genetic diagnoses: Hereditary hemorrhagic telangiectasia – juvenile polyposis syndrome (HHT-JPS) or familial adenomatous polyposis (FAP)?

Abstract A 26-year-old woman was diagnosed with hereditary hemorrhagic telangiectasia – juvenile polyposis syndrome (HHT-JPS) after an incidental finding of a pulmonary arteriovenous malformation. Molecular genetic testing confirmed the presence of a pathogenic SMAD4 variant, later found to be present in several other family members who were all previously labelled as having familial adenomatous polyposis. This short report contrasts and compares the conditions and highlights the importance of using genetic testing to distinguish similar presentations of gastrointestinal polyps in association with genetic conditions such as HHT-JPS and FAP. We highlight that detection of SMAD4 mutations can distinguish individuals with HHT-JPS from those with FAP who do not appear to present with arteriovenous malformations or notable criteria for HHT. This distinction may have significant implications for those with a longstanding familial diagnosis of FAP, as HHT-JPS entails different management considerations.

Authors

Institutions

Publication Details

Journal
Clinical and investigative medicine
Published
2026-08-26
DOI
https://doi.org/10.3138/cim-2026-0004
Primary Topic
Vascular Anomalies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Verifying genetic diagnoses: Hereditary hemorrhagic telangiectasia – juvenile polyposis syndrome (HHT-JPS) or familial adenomatous polyposis (FAP)?

Harry Wilton-Clark, Mitchell Wagner, Sergio Zepeda-Gómez, Alexander Beke et al.
Clinical and investigative medicine
Vascular Anomalies and Treatments
article

Verifying genetic diagnoses: Hereditary hemorrhagic telangiectasia – juvenile polyposis syndrome (HHT-JPS) or familial adenomatous polyposis (FAP)?

Harry Wilton-Clark, Mitchell Wagner, Sergio Zepeda-Gómez, Alexander Beke, Dilini Vethanayagam
article en

Abstract

Abstract A 26-year-old woman was diagnosed with hereditary hemorrhagic telangiectasia – juvenile polyposis syndrome (HHT-JPS) after an incidental finding of a pulmonary arteriovenous malformation. Molecular genetic testing confirmed the presence of a pathogenic SMAD4 variant, later found to be present in several other family members who were all previously labelled as having familial adenomatous polyposis. This short report contrasts and compares the conditions and highlights the importance of using genetic testing to distinguish similar presentations of gastrointestinal polyps in association with genetic conditions such as HHT-JPS and FAP. We highlight that detection of SMAD4 mutations can distinguish individuals with HHT-JPS from those with FAP who do not appear to present with arteriovenous malformations or notable criteria for HHT. This distinction may have significant implications for those with a longstanding familial diagnosis of FAP, as HHT-JPS entails different management considerations.

Clinical and investigative medicine
University of Alberta (CA), Alberta Hospital Edmonton (CA)
Good health and well-being
Openalex Percentile: Top 11%
Vascular Anomalies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Verifying genetic diagnoses: Hereditary hemorrhagic telangiectasia – juvenile polyposis syndrome (HHT-JPS) or familial adenomatous polyposis (FAP)? — Harry Wilton-Clark, Mitchell Wagner, et al. · Clinical and investigative medicine (2026) | TGRS Research Map | TGRS